The orchid Prosthechea karwinskii is a medicinal orchid in Oaxaca, Mexico, used to treat diabetes, cough, wounds, and burns, prevent miscarriage and assist in labor. Each part of the plant (leaves, pseudobulbs, or flowers) is used by healers for certain treatment conditions, indicating that each part has different biocompounds with specific pharmacological activity. To characterize the biocompounds in extracts from leaves, pseudobulbs, and flowers of P. karwinskii and evaluate their ROS inhibition capacity to associate it with medicinal uses. The compounds present in extracts from leaves, pseudobulbs, and flowers of P. karwinskii were identified by UPLC-ESI-qTOF-MS/MS. The chemical differentiation of each extract was tested by principal component analysis (PCA) using compound intensity values. For each extract, total phenol and flavonoid contents were quantified. Their antioxidant capacity was evaluated ex vivo by inhibition of ROS with DCFH-DA and in vitro with DPPH radical. Based on the PCA, it was observed that some compounds were completely separated from others according to the correlation that they presented. The compounds common to all three plant parts were quinic, malic, succinic, azelaic, and pinellic acids. Among the compounds identified, two were exclusive to leaves, four to pseudobulbs, and ten to flowers. Some of the identified compounds have well-known antioxidant activity. The leaves had the highest content of total phenols and flavonoids, and the highest in vitro and ex vivo antioxidant capacity. A strong correlation was observed between phenol and flavonoid contents, and antioxidant capacity ex vivo and in vitro. It was found that the bioactive compounds and antioxidant capacity of each part of the plant were associated with its traditional medicinal use. A pharmacological potential was also found in P. karwinskii for further biological studies because of the type of compounds it contained.

Prosthechea karwinskii is an endemic orchid of Mexico with significant value for its traditional uses: ornamental, ceremonial, and medicinal. The pharmacological activity of this plant has been studied using specimens recovered from religious use during Holy Week in Oaxaca, Mexico, sourced from various localities within this state. Geographical variability can influence the chemical composition of plants, as environmental factors affect the production of their secondary metabolites, which impact their biological properties. This research evaluated the variability in the chemical composition of leaves and pseudobulbs of P. karwinskii obtained from different localities in Oaxaca, comprising 95–790 g and 376–3900 g of fresh material for leaves and pseudobulbs, respectively, per locality. Compounds were identified using UHPLC-ESI-qTOF-MS/MS following ultrasound-assisted hydroethanolic extraction. Twenty-one compounds were identified in leaves and twenty in pseudobulb. The findings revealed differences in chemical composition across localities and between leaves and pseudobulbs of the species. The Roaguia locality exhibited the highest extraction yield and pharmacological potential in leaves. For pseudobulbs, Cieneguilla specimens showed the highest yield, and El Lazo had the lowest yield but the highest pharmacological potential. This study represents the first comprehensive analysis of the variation in the chemical composition of a native Mexican orchid. In all localities, leaves and pseudobulbs contained compounds with known biological activity, validating the use of the species in traditional medicine and highlighting its potential for medical and biological applications.

Prosthechea karwinskii is an endemic orchid of Mexico with cultural significance for its ornamental, food, religious, and medicinal uses. In traditional medicine, diabetic patients use the leaves of this plant to lower glucose levels. The present study evaluated the effect of P. karwinskii leaves extract on the antioxidant enzymes superoxide dismutase (SOD) and catalase (CAT) in a model of obese rats with insulin resistance for its nutraceutical potential to reduce insulin resistance and oxidative stress. Obesity and insulin resistance were induced with 40% sucrose in water for 20 weeks. Four groups (control rats, obese rats, obese rats administered the extract, and obese rats administered metformin) were evaluated. Extract compounds were identified by UHPLC-ESI-qTOF-MS/MS. Glucose, insulin, triglyceride, and insulin resistance indices (HOMA-IR and TyG), as well as the activity of the antioxidant enzymes, increased in rats in the obese group. Administration of P. karwinskii extract and metformin reduced glucose, insulin, triglyceride, and insulin resistance indices and antioxidant enzyme activity to values similar to those of the control group. Therefore, this study shows the nutraceutical potential of P. karwinskii extract as an ingredient in the formulation of dietary supplements or functional foods to help treat diseases whose pathophysiology is related to oxidative stress and insulin resistance.

Cardiovascular disease (CVD) is one of the leading causes of death worldwide. Metabolic syndrome (MS) promotes the development of CVD. Patients with MS present obesity, dyslipidemia, inflammation, hyperglycemia, insulin resistance, and oxidative stress; parameters that are closely related to the development of CVD. The Mexican orchid Prosthechea karwinskii is used in traditional medicine to treat various ailments, which is attributed to the compounds it contains. The extract of leaves of this orchid has demonstrated effects such as inhibition of reactive oxygen species (related to oxidative stress), in addition to decreasing body weight, pericardial fat, glucose, insulin resistance, proinflammatory markers, as well as increasing adiponectin levels in a Wistar rat model with MS. In addition, some of the compounds identified in this plant have reported biological activity related to CVD. All this indicates that this orchid has the potential as an alternative multi-target treatment for protection against CVD.